Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders

Chest

Volumn 139, Issue 5, 2011, Pages 1060-1071

  Young, Lisa R ^a   Brody, Alan S ^a   Inge, Thomas H ^a   Acton, James D ^a   Bokulic, Ronald E ^a   Langston, Claire ^b   Deutsch, Gail H ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; KI 67 ANTIGEN;

ADOLESCENT; AIRWAY OBSTRUCTION; ARTICLE; CELL COUNT; CELL HYPERPLASIA; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; LUNG BIOPSY; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; NEUROENDOCRINE CELL HYPERPLASIA OF INFANCY; NEUROSECRETORY CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SMALL AIRWAY DISEASE; SYMPTOMATOLOGY;

EID: 79955749250     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-1304     Document Type: Article

References (38)

1. Deterding RR, Fan LL, Morton R, Hay TC, Langston C. Persistent tachypnea of infancy (PTI) - a new entity. Pediatr Pulmonol. 2001;( suppl 23):72-73. (Pubitemid 33021806)
2. Deterding RR, Pye C, Fan LL, Langston C. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol. 2005;40(2):157-165. (Pubitemid 41099432)
3. Brody AS, Crotty EJ. Neuroendocrine cell hyperplasia of infancy (NEHI). Pediatr Radiol. 2006;36(12):1328. (Pubitemid 44920876)
4. Brody AS, Guillerman RP, Hay TC, et al. Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. AJR Am J Roentgenol. 2010;194(1):238-244.
5. Langston C, Dishop MK. Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies. Pediatr Dev Pathol. 2009;12(6):421-437.
6. Willey JC, Lechner JF, Harris CC. Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. Exp Cell Res. 1984;153(1):245-248. (Pubitemid 14088421)
7. Sunday ME, Hua J, Dai HB, Nusrat A, Torday JS. Bombesin increases fetal lung growth and maturation in utero and in organ culture. Am J Respir Cell Mol Biol. 1990;3(3):199-205.
8. King KA, Torday JS, Sunday ME. Bombesin and [Leu8] phyllolitorin promote fetal mouse lung branching morphogenesis via a receptor-mediated mechanism. Proc Natl Acad Sci U S A. 1995;92(10):4357-4361.
9. Lauweryns JM, Cokelaere M, Deleersynder M, Liebens M. Intrapulmonary neuro-epithelial bodies in newborn rabbits. Influence of hypoxia, hyperoxia, hypercapnia, nicotine, reserpine, L-DOPA and 5-HTP. Cell Tissue Res. 1977;182(4):425-440.
10. Sunday ME. Tissue-specific expression of the mammalian bombesin gene. Ann N Y Acad Sci. 1988;547:95-113.
11. Nakatani Y. Pulmonary endocrine cells in infancy and childhood. Pediatr Pathol. 1991;11(1):31-48.
12. Perrin DG, McDonald TJ, Cutz E. Hyperplasia of bombesinimmunoreactive pulmonary neuroendocrine cells and neuroepithelial bodies in sudden infant death syndrome. Pediatr Pathol. 1991;11(3):431-447.
13. Johnson DE, Lock JE, Elde RP, Thompson TR. Pulmonary neuroendocrine cells in hyaline membrane disease and bronchopulmonary dysplasia. Pediatr Res. 1982;16(6):446-454. (Pubitemid 12117217)
14. Sunday ME, Kaplan LM, Motoyama E, Chin WW, Spindel ER. Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest. 1988;59(1):5-24.
15. Johnson DE, Anderson WR, Burke BA. Pulmonary neuroendocrine cells in pediatric lung disease: alterations in airway structure in infants with bronchopulmonary dysplasia. Anat Rec. 1993;236(1):115 -119, 172-173.
16. Cutz E, Perrin DG, Pan J, Haas EA, Krous HF. Pulmo nary neuroendocrine cells and neuroepithelial bodies in sudden infant death syndrome: potential markers of airway chemoreceptor dysfunction. Pediatr Dev Pathol. 2007;10( 2):106-116. (Pubitemid 46580401)
17. Schindler MB, Bohn DJ, Bryan AC, Cutz E, Rabinovitch M. Increased respiratory system resistance and bronchial smooth muscle hypertrophy in children with acute postoperative pulmonary hypertension. Am J Respir Crit Care Med. 1995;152( 4 pt 1):1347-1352.
18. Johnson DE, Wobken JD, Landrum BG. Changes in bombesin, calcitonin, and serotonin immunoreactive pulmonary neuroendocrine cells in cystic fibrosis and after prolonged mechanical ventilation. Am Rev Respir Dis. 1988;137(1):123-131. (Pubitemid 18032837)
19. Scher H, Miller YE, Aguayo SM, Johnson KJ, Miller JE, McCray PB Jr. Urinary bombesin-like peptide levels in infants and children with bronchopulmonary dysplasia and cystic fibrosis. Pediatr Pulmonol. 1998;26(5):326-331. (Pubitemid 29006564)
20. Stevens TP, McBride JT, Peake JL, Pinkerton KE, Stripp BR. Cell proliferation contributes to PNEC hyperplasia after acute airway injury. Am J Physiol. 1997;272(3 pt 1):L486-L493.
21. Reynolds SD, Giangreco A, Power JH, Stripp BR. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol. 2000;156(1):269-278. (Pubitemid 30644460)
22. Castile R, Filbrun D, Flucke R, Franklin W, McCoy K. Adulttype pulmonary function tests in infants without respiratory disease. Pediatr Pulmonol. 2000;30(3):215-227.
23. Jones M, Castile R, Davis S, et al. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med. 2000;161(2 pt 1):353-359. (Pubitemid 30129438)
24. American Thoracic Society; European Respiratory Society. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med. 2005;172(11):1463-1471.
25. Kerby GS, Kopecky C, Wilcox SL, et al. Infant pulmonary function testing in children with neuroendocrine cell hyperplasia with and without lung biopsy. Am J Respir Crit Care Med. 2009;179:A3671.
26. Nicholson AG, Bush A. Classification of diffuse lung disease in infants: the reality of groups. Am J Respir Crit Care Med. 2007;176(11):1060-1061. (Pubitemid 350223750)
27. McBride JT, Springall DR, Winter RJ, Polak JM. Quantitative immunocytochemistry shows calcitonin gene-related peptidelike immunoreactivity in lung neuroendocrine cells is increased by chronic hypoxia in the rat. Am J Respir Cell Mol Biol. 1990;3(6):587-593.
28. Shenberger JS, Shew RL, Johnson DE. Hyperoxia-induced airway remodeling and pulmonary neuroendocrine cell hyperplasia in the weanling rat. Pediatr Res. 1997;42(4):539-544. (Pubitemid 27411164)
29. Deutsch GH, Young LR, Deterding RR, et al; Pathology Cooperative Group; ChILD Research Co-operative. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176(11):1120-1128. (Pubitemid 350223758)
30. Wang D, Yeger H, Cutz E. Expression of gastrin-releasing peptide receptor gene in developing lung. Am J Respir Cell Mol Biol. 1996;14(5):409-416. (Pubitemid 126440509)
31. Sunday ME, Willett CG, Patidar K, Graham SA. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia. Lab Invest. 1994;70(6):875-888. (Pubitemid 24209489)
32. Popler J, Gower W, Mogayzel P Jr, et al. Familial neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol; 2010;45(8):749-755.
33. Davies SJ, Gosney JR, Hansell DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia:an underrecognised spectrum of disease. Thorax. 2007;62(3):248-252. (Pubitemid 46579807)
34. Cutz E, Yeger H, Pan J. Pulmonary neuroendocrine cell system in pediatric lung disease-recent advances. Pediatr Dev Pathol. 2007;10(6):419-435. (Pubitemid 350305238)
35. Skogvall S, Korsgren M, Grampp W. Evidence that neuroepithelial endocrine cells control the spontaneous tone in guinea pig tracheal preparations. J Appl Physiol. 1999;86(3):789-798. (Pubitemid 29117995)
36. Yule KA, White SR. Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin. Exp Lung Res. 1999;25(3):261-273. (Pubitemid 29210663)
37. Subramaniam M, Sugiyama K, Coy DH, et al. Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? Am J Respir Crit Care Med. 2003;168(5):601-611.
38. Tjen-A-Looi S, Ekman R, Lippton H, Cary J, Keith I. CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension. Am J Physiol. 1992;263(3 pt 2):H681-H690.